Almost £1bn Spent on Anti-Covid Drug that Makes ‘No Significant Difference’
February 13th, 2023It gets better: COVID Drug Drives Viral Mutations
Via: Telegraph:
Almost £1 billion of taxpayers’ money has been wasted on an anti-Covid drug that makes “no significant difference”, The Telegraph can disclose.
Less than two per cent of the 2.23 million courses of the antiviral drug molnupiravir procured by the Department of Health have ever been prescribed to patients, analysis by The Telegraph shows.
The rest are unlikely to ever be used after research found the drug makes “no significant difference” to hospitalisation or death rates.
